News Search
11.06.2020
GRATA International became a Mondaq Contributor With Most Reader Response In Kazakhstan
In May 2020 GRATA International in Kazakhstan became the most read contributor among other authors.
04.06.2020
Samat Daumov, Partner of GRATA International became a graduate of the first training course of the Investor School at the Astana Hub International Technology Park of IT startups
This intensive course is provided for venture capital investments for investors and business angels. The course program is aimed at creating a holistic view of the methodology for evaluating and investing in technology companies.
03.06.2020
Askar Konysbayev promoted to the position of Head of the Litigation Department
We are pleased to announce the promotion of Askar Konysbayev to the position of Head of the Litigation Department from 1 June 2020.
Kanat Adilbekov, Counsel of GRATA International, spoke on the webinar on legal issues
On May 27, 2020, an online webinar of the European Business Association of Kazakhstan was held on the topic: "Changes in the legislation and practice of considering legal disputes on the issues of recognition of transactions as invalid by state revenue authorities"
GRATA International spoke at the meeting of the Tax, Customs & Law Working Group
On May 6, 2020, the Union of German Economy in the Republic of Kazakhstan held a working meeting in the framework of the Emergency period.
GRATA International in Nur Sultan held a joint webinar with AIFC
On April 21, 2020, a webinar on the topic «Covid-19: Legal Aspects under the Law of Kazakhstan and AIFC» was held.
GRATA International attended the annual AIFC Legal Talks event
On April 17, 2020, the AIFC Legal Talks event was held in webinar format on the theme: “How to use the AIFC Law online”.
GRATA International held the meeting of the Working Group on Legal Issues at the CCI France-Kazakhstan
The online meeting of the working group on legal issues was held on April 14, 2020. Theme of the meeting: "Some issues of emergency in connection with the epidemic COVID-19."